Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Dexmedetomidine

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed2
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Research Network

Common Treatments

  • Dexmedetomidine1
  • Dural Puncture Epidural Technique Using Pencilpoint 25g Whitacre Needle1
  • Intrathecal 16 Ml 075 Bupivacaine In 825 Dextrose Combined With 15 Mcg Fentanyl And 150 Mcg Preservativefree Morphine1
  • Bupivacaine1
  • Dural Puncture Epidural Technique Using Pencilpoint 27g Whitacre Needle1

Active Sponsors

  • Reham Ali Abdelhaleem Abdelrahman2
  • Oregon Health and Science University1

Top Investigators

Related Conditions

  • Cesarean Section1

Activity Timeline